Skip to main content
OpenTrials
Not Yet Recruiting

NCT Number: NCT07182201

Effect of Foot Core Control Training on Dorsiflexion Function and Gait Biomechanical Characteristics of Patients With Chronic Plantar Fasciitis

The pain and abnormal gait postures observed in CPF patients may be associated with impaired foot function. However, few studies have examined the dorsiflexion function of the big toe in CPF patients, and the effectiveness of foot core control training in alleviating pain and improving gait remains unclear. Restricted movement of the metatarsophalangeal joint (MTPJ1) may severely compromise foot function, leading to gait pattern alterations and subsequent instability. To address this, our study aims to improve symptoms, functional outcomes, and gait through foot core control training interventions. We recorded kinematic parameters and biomechanical data during the foot's plantar phase at toe-off before and after functional training for CPF patients. Comparative analysis between intervention groups revealed whether foot core control training can effectively enhance big toe dorsiflexion function and gait biomechanics in CPF patients. This research clarifies the therapeutic efficacy of foot core control training for CPF patients.

Not Yet Recruiting

Trial opening soon.

Get Notified

Key information

Age range

25 year–45 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • (1) Ultrasound findings indicating plantar fascia thickness>4 mm or 20% thickening compared to the contralateral side; (2) Age 25-45 years; (3) Ankle dorsiflexion range <65° in weight-bearing standing position; (4) Persistent heel pain lasting ≥3 months but ≤1 year; (5) No prior treatment within 1 month prior to hospital admission; (6) Subjects without prior CPF surgical intervention.

Exclusion criteria

  • (1) Concurrent presence of severe malignant diseases; (2) Abnormal conditions such as skin ulcers or infections on the sole; (3) Concurrent neurological or immunological disorders; (4) Concurrent heel deformity or fracture; (5) Secondary CPF caused by rheumatoid arthritis, ankylosing spondylitis, or other conditions; (6) Concurrent cognitive impairment, mental abnormalities, or difficulty completing relevant assessment scales.

Treatment and study plan

Foot core control training

Behavioral

(1) Toe Yoga : When MTPJ1 actively dorsiflexes, the other four toes remain in contact with the ground. The subject lifts the big toe while the remaining four toes stay on the ground; conversely, when the big toe contacts the ground, the other four toes lift upward, alternating this pattern. (2)Doming: While keeping MTPJ1 in contact with the ground, elevate the foot arch. This exercise strengthens intrinsic foot muscle strength, helping stabilize the arch and first metatarsal. The subject tightens the toes, bringing the forefoot toward the heel to form and enhance the arch. Maintain all toes firmly planted on the ground, ensuring no ankle inversion, no forced flexion or extension of toes, and hold at maximum position. Perform training seated to avoid compensatory movements by external muscles during exercise. (3) Toe Abduction Exercises(4)Dynamic Exercise Progression

CPF Conventional training

Behavioral

The key points of the exercise are as follows: (1) Fascia ball release of plantar fascia (2) Plantar fascia stretching (3) Gastrocnemius muscle stretching (4) Toe grab towel

Primary outcomes

  1. Vicon 3D gait test

    Time frame: 30 minutes

    subjects wore athletic shorts, fully exposing the waist and the area below the mid-thigh. After reflective markers were attached, subjects familiarized themselves with the movement collection requirements and procedures according to the testing protocol. They stood in the center of the testing room with their feet shoulder-width apart and upper limbs resting naturally at their sides, maintaining the subtalar joint in a neutral position. A static test was conducted to collect reference data for defining the coordinate systems of the bone segments. Subsequently, participants performed walking, jogging, side-cutting, jumping, and single-leg balance tasks at a self-selected comfortable pace. Sufficient rest was provided between trials to prevent fatigue. Five valid trials were collected for each movement, and the average of three trials was used for analysis.

  2. Evaluation of dorsiflexion function of big toe

    Time frame: 30 minutes

    Goniometric measurement: The subject removes footwear and stands weight-bearing on a yoga mat, actively dorsiflexing the big toe. The tester measures the dorsiflexion angle of the big toe using a goniometer. The goniometer's axis is aligned with the big toe's MTPJ1, with the fixed arm parallel to the first metatarsal and the movable arm parallel to the first proximal phalanx. The movable arm is adjusted according to the subject's dorsiflexion angle, with measurements recorded. Three trials are performed and averaged.

    Vicon measurement: The subject's MTPJ1 angle during walking is recorded using Vicon technology.

Secondary outcomes

  1. Visual analog scale (VAS)

    Time frame: 5minutes

  2. ankle and hindfoot function scale (AOFAS)

    Time frame: 5 minutes

Study contacts

Contact information is provided by the study sponsor or research team.

Hongshi Huang

CONTACT

[email protected]

15522336527

Sponsors and collaborators

Lead sponsor

Peking University Third Hospital

Other

Registry information

Important dates

Study start
2025
Primary completion
2025
Study completion
2025
First posted
Sep 19, 2025
Registry last updated
Sep 19, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.